DE60036047D1 - Gealtelter Haut-äquivalent, deren Herstellungsverfahren und Verwendungen - Google Patents

Gealtelter Haut-äquivalent, deren Herstellungsverfahren und Verwendungen

Info

Publication number
DE60036047D1
DE60036047D1 DE60036047T DE60036047T DE60036047D1 DE 60036047 D1 DE60036047 D1 DE 60036047D1 DE 60036047 T DE60036047 T DE 60036047T DE 60036047 T DE60036047 T DE 60036047T DE 60036047 D1 DE60036047 D1 DE 60036047D1
Authority
DE
Germany
Prior art keywords
equivalent
aged
aged skin
fibroblasts
skin equivalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036047T
Other languages
English (en)
Other versions
DE60036047T2 (de
DE60036047T3 (de
Inventor
Herve Pageon
Daniel Asselineau
Pierre Tachon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9544638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60036047(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE60036047D1 publication Critical patent/DE60036047D1/de
Publication of DE60036047T2 publication Critical patent/DE60036047T2/de
Application granted granted Critical
Publication of DE60036047T3 publication Critical patent/DE60036047T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C12N2503/06—Screening or testing on artificial skin
DE60036047T 1999-04-20 2000-04-18 Äquivalent der Altershaut, Verfahren zu seiner Herstellung und seine Verwendung Expired - Lifetime DE60036047T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904970A FR2792650B1 (fr) 1999-04-20 1999-04-20 Equivalent de peau agee, son procede de preparation et son utilisation
FR9904970 1999-04-20
EP00401073A EP1046402B2 (de) 1999-04-20 2000-04-18 Gealtelter Haut-äquivalent, deren Herstellungsverfahren und Verwendungen

Publications (3)

Publication Number Publication Date
DE60036047D1 true DE60036047D1 (de) 2007-10-04
DE60036047T2 DE60036047T2 (de) 2008-05-21
DE60036047T3 DE60036047T3 (de) 2012-07-26

Family

ID=9544638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036047T Expired - Lifetime DE60036047T3 (de) 1999-04-20 2000-04-18 Äquivalent der Altershaut, Verfahren zu seiner Herstellung und seine Verwendung

Country Status (8)

Country Link
US (3) US6605466B1 (de)
EP (1) EP1046402B2 (de)
JP (1) JP3387891B2 (de)
AT (1) ATE370755T1 (de)
CA (1) CA2306317C (de)
DE (1) DE60036047T3 (de)
ES (1) ES2292412T5 (de)
FR (1) FR2792650B1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622117B2 (en) * 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
RU2301800C2 (ru) * 2002-04-19 2007-06-27 Аризона Боард Оф Ридженс Он Бихав Оф Зе Юниверсити Оф Аризона Способ модулирования фототоксичности
FR2847345B1 (fr) * 2002-11-18 2005-02-18 Oreal Procede de criblage et/ou d'evaluation de l'activite anti-ride de produits
FR2847268B1 (fr) * 2002-11-19 2006-09-29 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes soumises a un stress et des cellules vivantes non soumises a ce meme stress
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
US7169382B2 (en) * 2003-01-30 2007-01-30 L'oreal Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds
FR2878035B1 (fr) 2004-11-15 2014-10-17 Oreal Dispositif comportant un echantillon de peau reconstruite et un systeme de detection.
US8399349B2 (en) * 2006-04-18 2013-03-19 Air Products And Chemicals, Inc. Materials and methods of forming controlled void
FR2903702B1 (fr) * 2006-07-13 2012-10-19 Oreal Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation
JPWO2008108155A1 (ja) * 2007-03-01 2010-06-10 ポーラ化成工業株式会社 抗シワ物質の評価法及び皮膚の鑑別法
JP2007313333A (ja) * 2007-06-08 2007-12-06 Kao Corp 再構成皮膚の構築方法
US20090195696A1 (en) * 2008-01-07 2009-08-06 Toshiba America Consumer Products, Llc Channel system and method
CN102085392B (zh) * 2011-01-28 2013-04-10 成都维德医疗器械有限责任公司 纳米钙磷盐/胶原复合支架及其制备方法与应用
DE102012223061A1 (de) * 2012-12-13 2014-06-18 Henkel Ag & Co. Kgaa Altershautmodell
FR3007037B1 (fr) * 2013-06-18 2016-07-29 Clarins Lab Modele d'epiderme reconstruit presentant des caracteristiques des taches de vieillesse
CN103788139B (zh) * 2014-02-17 2016-10-05 青岛大学 具抗癌活性的昆布氨酸希夫碱异双核配合物的合成及其药物组合物
CN104368043B (zh) * 2014-09-25 2016-02-24 浙江星月生物科技股份有限公司 一种胶原基质软骨修复膜、制备方法及应用
KR101778047B1 (ko) * 2016-04-04 2017-09-13 스페클립스 주식회사 질병 진단과 피부 나이 측정이 가능한 시스템과 이에 사용되는 핸드피스
FR3054449B1 (fr) 2016-07-29 2018-08-31 L'oreal Equivalent de peau a compartiments dermiques juxtaposes distincts
KR102540981B1 (ko) * 2017-06-30 2023-06-08 (주)아모레퍼시픽 인공피부 제조방법 및 인공피부
KR102213922B1 (ko) * 2017-06-30 2021-02-08 (주)아모레퍼시픽 인공피부 제조방법 및 인공피부
KR20190130358A (ko) * 2018-05-14 2019-11-22 (주)아모레퍼시픽 콜라겐 젤 강도 조절제, 이를 이용한 인공피부 제조방법 및 인공피부
KR102127597B1 (ko) 2019-03-22 2020-06-29 스페클립스 주식회사 레이저 유도 붕괴 스펙트럼 분석을 이용하는 진단 방법 및 이를 수행하는 진단 장치
JP7069270B2 (ja) * 2020-10-13 2022-05-17 モリンダ インコーポレーテッド Ａｇｅ由来メラニン産生方法及び組成物
KR102466098B1 (ko) * 2021-01-12 2022-11-11 주식회사 클리셀 인간피부의 진피능선 구현과 진피층 당화를 유발시킨 인공피부모델 및 이의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US618793A (en) * 1899-01-31 Printing-machine
US4971954A (en) * 1988-11-23 1990-11-20 University Of Medicine And Dentistry Of New Jersey Collagen-based matrices ribose cross-linked
JPH0747043B2 (ja) * 1990-04-24 1995-05-24 エイゼンバーグ，マーク 合成生体皮膚等価物
IT1248934B (it) 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
GB9026384D0 (en) 1990-12-05 1991-01-23 Vitaphore Wound Healing Wound dressings and processes for manufacture thereof
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AU698317B2 (en) * 1995-02-25 1998-10-29 Cancer Research Technology Limited Transgenic animals as model of psoriasis
FR2743817B1 (fr) 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans

Also Published As

Publication number Publication date
US20040052772A1 (en) 2004-03-18
ES2292412T5 (es) 2012-06-28
US6605466B1 (en) 2003-08-12
EP1046402B2 (de) 2012-04-04
CA2306317A1 (fr) 2000-10-20
EP1046402A1 (de) 2000-10-25
JP2000350778A (ja) 2000-12-19
ES2292412T3 (es) 2008-03-16
JP3387891B2 (ja) 2003-03-17
CA2306317C (fr) 2012-01-10
DE60036047T2 (de) 2008-05-21
US6660522B2 (en) 2003-12-09
FR2792650B1 (fr) 2003-02-28
EP1046402B1 (de) 2007-08-22
DE60036047T3 (de) 2012-07-26
US6890754B2 (en) 2005-05-10
ATE370755T1 (de) 2007-09-15
FR2792650A1 (fr) 2000-10-27
US20020058337A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
DE60036047D1 (de) Gealtelter Haut-äquivalent, deren Herstellungsverfahren und Verwendungen
RU2000104878A (ru) Композиция для ухода за кожей
BR9610028A (pt) Processos para aumentar a longo prazo o tecido subcutâneo ou dérmico em um indivíduo humano, para fazer um dispositivo, e, para reparar sequelas de acne vulgaris em um indivíduo e dispositivo para reparar um defeito dérmico em um indivíduo.
BR9915476A (pt) Construtos de tecidos feitos por bioengenharia e métodos para a sua produção e utilização
ATE73644T1 (de) Kosmetisches mittel.
DE69726772D1 (de) Hautäquivalent, das Langerhans-Zellen enthält
DE3884427D1 (de) Polyquaternaere polysiloxan-polymere, deren herstellung und verwendung in kosmetischen zubereitungen.
DE69106121T2 (de) Synthetisches poröses kristallines material, dessen herstellung und verwendung.
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
DE60204352D1 (de) Haut/haar-äquivalent mit rekonstruierten papillen
AR003410A1 (es) Composicion para reducir el crecimiento capilar en mamiferos y metodo para producir dicha composicion
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
AU7634801A (en) Three-dimensional skin model
EP1372549A4 (de) Orthopädische gipstechnik mit versiegeltem rand
ES2043957T3 (es) Composicion obtenida a partir de cortezas de arroz y procedimiento para su preparacion.
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE69831404D1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
AU2003286410A1 (en) Methods of producing lignin peroxidase and its use in skin and hair lightening
ES2093536T3 (es) Uso de acidos sulfonicos como agentes antienvejecimiento en una composicion cosmetica o dermatologica.
DE59004498D1 (de) Verfahren zur Herstellung von segmentierten Polyurethanharnstoff-Elastomerlösungen, sowie Fäden und Folien daraus.
ATE96009T1 (de) Kosmetische oder pharmazeutische zusammensetzung zur topischen verwendung die mindestens ein retinoid-derivat und mindestens ein pyrimidin- derivat enthaelt.
ATE123409T1 (de) Verwendung von vitamin d verbindungen zur herstellung einer kosmetischen zusammensetzung und anwendung dieser zur verbesserung der hautbeschaffenheit.
DE50100859D1 (de) Hautmatrix zur Abdeckung und Regenerierung verletzter Hautpartien sowie Verfahren zu ihrer Herstellung
DE69900160T2 (de) Zusammensetzung, die Harnstoff enthält, und ihre Verwendungen in der Kosmetik und/oder Dermatologie
EP0338459A3 (de) Haarwuchsfördernde Zusammensetzung in androgenetischer Alopezie und Verfahren zur Anwendung dieses Präparates zum Fördern des Haarwuchses

Legal Events

Date Code Title Description
8363 Opposition against the patent